Northern United Pharmaceutical finally selected the factory site in He@bei.

It is difficult to find land in the capital. Even if it is outside the Sixth Ring Road, no one wants it, you can’t imagine approving tens of thousands of acres of land in one go.

More than 30 years after the founding of the People's Republic of China, various units and departments have long occupied large plots of land. In the remaining wilderness, there are either backup land left by the government or various disputes. In addition, there are also state-owned farms and logistics farms.

Although Hu Chi came out of Qiao and served as the director of the Chemical and Drug Revitalization Office, it was still a bit too challenging to have tens of thousands of acres of land in the suburbs of Beijing.

Furthermore, why can a unit like Northern United Pharmaceutical, where grandpas do not love grandmas, get tens of thousands of acres of land in the suburbs of Beijing?

After training in the military camp for almost two months, the workers took off their green military uniforms and put on their gray work clothes, they no longer had the feeling of resistance.

Thankfully, it is enough to preserve the respectable profession of state-owned enterprise workers.

As for the cadres of the original company, they were even more lucky.

If you can come back smoothly, there are already a few enterprises that have been disrupted and placed. All enterprises, including North China Pharmaceutical, are originally over-staffed. If a few companies merge, not to mention the result. Most people can only wait for work and then find work. If they can go to the county, they will be lucky.

The 1980s were originally a super-profile era.

Old cadres who are unwilling to retire, ordinary cadres who are normal and abnormally promoted, and unlucky cadres who have been rehabilitated have formed an extremely large era of officials. It is simply common for a full-time position and 11 deputy positions to be promoted.

The so-called historical legacy issues are just like this. Rehabilitation is a major policy, and cadres who have been rehabilitated naturally need to arrange it. There is no reason for cadres who have been promoted to give way to rehabilitation cadres. As for the old cadres who do not retire, it is to help you, and it is the final luminous and heat. Before there is no policy of retiring, everyone is loyal to the country.

To a certain extent, people in the 1980s were actually very accustomed to this phenomenon.

Sometimes, more deputy positions also form a short-term relative check and balance.

That kind of situation where the top leader is dominant was not easy to achieve in the middle and high-level leaders in the 1980s. Not to mention, the old revolutionaries during the Red Army period are still there. Even if middle-aged and young cadres are promoted, can they point at the nose of the old revolutionary? In turn, it is almost the same.

However, Yang Rui did not have such a concept, and he was even more unwilling to be so bloated in the new Northern United Pharmaceutical.

Hu Chi now trusted him so he drove away the extra cadres with great care. Not only that, Northern United Pharmaceuticals even lacked staff, especially grassroots positions, with a large number of vacancies, and put on an attitude of being able to go on, which stimulated the workers who had just finished military training.

The only thing that makes it difficult for workers, or some workers, to adapt is their current work content.

"Why can others install machines and build factories? I have to feed mice!" Fang Zhengye changed into a white coat and rubber gloves, but he did not have the joy of wearing new clothes at all.

"This one is not called a mouse, it is called a Chinese hamster." Duan Chang received temporary training and gave a casual sentence.

"If there are too many rats in China, can we raise them? I have never seen anyone who messes with people like this." Fang Zhengye's dissatisfaction will not be reduced at all.

The worker next to him said, "They use it to make medicine."

"With mice as medicine, isn't they nausea? I'd rather die than take it."

"The patient doesn't think so. The Chinese hamsters we raised here finally extracted cells, which can treat Gaucher's disease. It is said that hundreds of thousands of people around the world got this disease and died in a few years." Duan Zhang's temper was quite good, and it was because of his good temper that he was sent to this workshop. Duan Zhang who always wanted to wheel wrenches went to the machinery and manufacturing workshops.

"Then the hundreds of thousands of people are cured, and our workshop will be cut off?" Another worker heard the chat and came over.

Duan Chang shook his head: "Goche's disease cannot be cured, so he can only take medicine to maintain it."

"Always eat?"

“Yeah, I can’t stop.”

"That's not a pot of medicine."

Fang Zhengye said: "The medicine jar is better than the ashes jar."

"You understand now. If you understand, you will go to work if you understand. I will tell you that our workshop is the core workshop. Do you know? There is a lot of potential in the future."

"The core is not just a mouse." Fang Zhengye muttered, while picking up the feeding dustpan in disgust and starting to feed one cage at a time.

The drug for Gaucher's disease is the ovarian cells of Chinese hamsters using recombinant DNA. After early experiments, they can quickly enter the culture stage of cell lines, which is also called cell engineering.

However, raising mice is indeed a big project. There are so many biological laboratories and pharmaceutical institutions in China that actually have a large demand.

Later generations had special factories to do this business, which was a technology-intensive and man-intensive industry. Yang Rui opened a project for Northern United Pharmaceutical, which could also be regarded as reducing the cost of biology researchers across the country.

In addition to the "core workshop", a large number of ordinary workshops have entered a state of rapid construction.

In order to feed the large number of workers in the northern pharmaceutical industry, they basically inherited the previous drug production. Although it is difficult to obtain high profits by manufacturing a large number of ordinary drugs, it is not bad to ensure balance of income and expenditure.

In addition, licenses for producing drugs are also considered scarce resources.

Pharmaceutical companies in the 1980s were all state-owned enterprises, and it was not difficult for everyone to apply for a license plate of one or two, so they could not reflect the value of the license plate. Just like car owners in small cities, they could not understand the rare license plates in Beijing, Shanghai.

This is the last remnant of state-owned enterprises. In a few years, as private enterprises increase their demand for licenses, let alone a warehouse drug brand license, a license with ammonia plus yellowmin is rushed to a seven-digit asking price.

As an intangible asset, this is the advantage of Northern United Pharmaceutical. Its scale is large, and there are more production lines that can be opened and more drug brands can be saved. It will be no longer needed in the future. If you sell it casually, you can update the equipment in the factory.

As for now, Northern United Pharmaceutical continues to use the old equipment of the original factory, it can be regarded as a profit point in disguise - even if the production line cannot make money, the licenses retained or even newly applied licenses can always be exchanged for some money.

Chinese cadres like this traditional business model very much. They have been working in this area for decades and don’t think it’s too low to make cold medicine. It’s better than making traditional Chinese medicine. At least there is a chemical formula on the wall of our workshop.

In contrast, Jielikang has no concern about the first batch of workshops built after spending money.

They paid more than $30 million to exchange for a 49% stake, not for this simple product.

Jielikan is completely optimistic about the development of orphan drugs for Gaucher's disease. However, even with the standard of deferrosterone, Jielikan bets that Yang Rui will definitely pass the second phase of clinical practice.

Considering that deferrosterone has completed all milestones and the price is extremely high, Jelikan still gave a considerable premium to the orphan medicine for Gaucher disease.

In this regard, Yang Rui can only say: Those who believe in me will make money.

Recombinant DNA technology, in 1986, is still quite cutting-edge and high-end, with basically no use in large-scale pharmaceuticals, and many laboratories are still exploring it.

However, for Yang Rui, recombining DNA is too simple, okay?

After only one night, Yang Rui wrote down what he wanted to order.

If it weren't for avoiding shocking things, he would have to pretend to guide and inspire. This work would be subcontracted directly to scientific research dogs.
Chapter completed!